Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/2/25 17:22 | 3/31/25 | AMLX | Health | Drug | Pharmaceutical Preparations | Frates James M | MA | O | CFO | 3 | S | -116 | 7.51 | 0 | -15 | 318 | D | |||||||||||||||
4/2/25 17:14 | 3/31/25 | AMLX | Health | Drug | Pharmaceutical Preparations | Bedrosian Camille L | MA | O | Chief Me | 3 | S | -110 | 3.74 | 0 | -29 | 194 | D | |||||||||||||||
4/2/25 17:12 | 3/31/25 | AMLX | Health | Drug | Pharmaceutical Preparations | Mazzariello Gina | MA | O | GC | 8 | S | -193 | 4.56 | 0 | -42 | 188 | D | |||||||||||||||
4/2/25 16:57 | 3/31/25 | AMLX | Health | Drug | Pharmaceutical Preparations | Cohen Joshua B | MA | DO | Co-CEO | 7 | S | -393 | 5.31 | 0 | -74 | 3,355 | D | |||||||||||||||
4/2/25 16:52 | 3/31/25 | AMLX | Health | Drug | Pharmaceutical Preparations | Klee Justin B. | MA | DO | Co-CEO | 7 | S | -392 | 5.31 | 0 | -74 | 3,355 | D | |||||||||||||||
1/11/24 17:04 | 1/9/24 | AMLX | Health | Drug | Pharmaceutical Preparations | Yeramian Patrick D | MA | O | Chief Me | 1 | S | -46 | 16.33 | 0 | -3 | 206 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |